Abiomed (ABMD) Halted Ahead of FDA Meeting on Blood Pumps
Abiomed, Inc. (NASDAQ: ABMD) halted ahead of FDA advisory committee meeting over nonroller-type cardiopulmonary bypass blood pumps.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abiomed (ABMD) Reports FDA HDE Approval for the Impella RP
- Intercept Pharma (ICPT) Surges Higher as OCA Receives Breakthrough Therapy Designation in NASH
- Lucas Energy (LEI) Offers Financial Obligations And Operational Update
Create E-mail Alert Related CategoriesFDA, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!